Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results
Focused
on advancing
the next wave
of medicine for
inflammatory
diseases
Go THRD
Third Harmonic Bio is a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases. We are grounded in our purpose of developing novel therapeutics to meaningfully improve the lives of the patients we serve.
KIT inhibition of
mast cells
mast cells
holds the potential to achieve the clinical efficacy needed for broad symptomatic relief across a range of inflammatory disorders.
More Science
Our lead product candidate, THB335,
is expected to enter clinical trials during the second quarter of 2024.
More Programs
DO YOU HAVE WHAT IT TAKES TO GO THRD?
We’re looking for driven, big picture thinkers who are passionate about making medicines and building a great company.
More Careers
WHY THRD?
The unique opportunities
and collaborative culture
make working at THRD
truly extraordinary. Watch
to hear more on why we
think THRD is a special
place to work.
and collaborative culture
make working at THRD
truly extraordinary. Watch
to hear more on why we
think THRD is a special
place to work.